2024
Cost-effectiveness of screening and treating alcohol use and depression among people living with HIV in Zimbabwe: a mathematical modeling study
Su J, Yeo Y, Jeetoo M, Morojele N, Francis J, Shenoi S, Braithwaite R. Cost-effectiveness of screening and treating alcohol use and depression among people living with HIV in Zimbabwe: a mathematical modeling study. BMC Medicine 2024, 22: 481. PMID: 39428460, PMCID: PMC11492560, DOI: 10.1186/s12916-024-03674-8.Peer-Reviewed Original ResearchConceptsCognitive-behavioral therapyBackgroundAlcohol use disorderTreating alcohol useCompared to baselineLong-acting PrEPDepressive disorderTreat AUDUse disorderMDDMDD screeningAlcohol usePHQ-9Quality-adjusted life yearsAUDCost-effectiveness of screeningSub-Saharan African settingDisordersImpact of screeningIntervention costsHIV infectionHIV transmissionHIV reductionInterventionHIV outcomesHIV epidemic
2021
Alcohol Use and the Risk of Communicable Diseases
Morojele NK, Shenoi SV, Shuper PA, Braithwaite RS, Rehm J. Alcohol Use and the Risk of Communicable Diseases. Nutrients 2021, 13: 3317. PMID: 34684318, PMCID: PMC8540096, DOI: 10.3390/nu13103317.Peer-Reviewed Original ResearchConceptsCommunicable diseasesTreatment outcomesSevere acute respiratory syndrome coronavirus 2Respiratory infection/pneumoniaAcute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2Alcohol useDisability-adjusted life yearsSyndrome coronavirus 2Poor treatment outcomesCOVID-19 infectionAlcohol use disorderGlobal health concernIndividual-level interventionsDifferent communicable diseasesTB deathsImmunodeficiency virusCoronavirus 2Severe illnessUse disordersPneumoniaHeavy drinkersLife yearsHIV researchTuberculosis
2020
989. Pre-exposure Prophylaxis (PrEP) Short-Term Retention Among Heavy Alcohol Users in Rural South Africa
Grammatico M, Choi K, Moll A, Shenoi S. 989. Pre-exposure Prophylaxis (PrEP) Short-Term Retention Among Heavy Alcohol Users in Rural South Africa. Open Forum Infectious Diseases 2020, 7: s523-s523. PMCID: PMC7776627, DOI: 10.1093/ofid/ofaa439.1175.Peer-Reviewed Original ResearchAlcohol use disorderHazardous alcohol usePrEP deliveryCommunity-based modelAntiretroviral therapyHIV testingAlcohol usersYoung menSexual partnersAlcohol usePre-exposure prophylaxisHazardous alcohol usersInconsistent condom useDifferentiated service deliveryOne-month followHome addressParticipant's home addressHeavy alcohol usersPrEP initiatorsPill countMedian ageHIV servicesEligible participantsHIV preventionPrevention services759. Where can we find active TB? Case finding at community sites and alcohol based venues (ABVs) in rural South Africa
Choi K, Shenoi S, Moll A, Friedland G. 759. Where can we find active TB? Case finding at community sites and alcohol based venues (ABVs) in rural South Africa. Open Forum Infectious Diseases 2020, 7: s426-s426. PMCID: PMC7778049, DOI: 10.1093/ofid/ofaa439.949.Peer-Reviewed Original ResearchAlcohol Use Disorders Identification TestHazardous alcohol useActive TBTB casesAlcohol useCase detectionOlder ageMean AUDITActive TB diseaseUseful adjunctive strategyPrimary care clinicsHIV rapid testsCommunity health workersTuberculosis case detectionResource limited settingsCases of TBDisorders Identification TestSubstance abuse servicesTB diseaseRandom glucoseBlood pressureMedian ageCare clinicsAdjunctive strategiesRisk factors
2016
Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study
Helou E, Shenoi S, Kyriakides T, Landry ML, Kozal M, Barakat LA. Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study. Journal Of The International Association Of Providers Of AIDS Care (JIAPAC) 2016, 16: 261-266. PMID: 27903948, PMCID: PMC5423832, DOI: 10.1177/2325957416680028.Peer-Reviewed Original ResearchConceptsVirologic failureViral load levelsPill burdenAlcohol useHuman immunodeficiency virus (HIV) careLow-level HIV viremiaUndetectable viral load levelsAntiretroviral regimen changesAntiretroviral therapy changesExperienced virologic failureLow-level viremiaIntravenous drug useSubset of patientsFrequent clinic visitsPoor clinical outcomePossible risk factorsHepatitis C virusHIV viremiaMore comorbiditiesNonfailure groupVirologic suppressionVirological failureCD4 countConsecutive chartsClinic visits